中国畜牧兽医 ›› 2021, Vol. 48 ›› Issue (5): 1859-1867.doi: 10.16431/j.cnki.1671-7236.2021.05.038

• 临床兽医 • 上一篇    下一篇

GS-441524对自然感染的猫传染性腹膜炎的治疗效果观察

牟丹霞1, 董军1,2, 吴凡1, 李安琪2, 唐雅姝1, 王敏1, 吕艳丽1,2   

  1. 1. 中国农业大学动物医学院, 北京 100193;
    2. 中国农业大学动物医院, 北京 100193
  • 收稿日期:2020-09-14 出版日期:2021-05-20 发布日期:2021-05-20
  • 通讯作者: 吕艳丽 E-mail:luyanli@cau.edu.cn
  • 作者简介:牟丹霞(1996-),女,四川成都人,硕士,研究方向:犬猫传染病诊断与治疗,E-mail:727056504@qq.com;董军(1969-),男,北京人,博士,高级兽医师,研究方向:小动物临床诊断与治疗,E-mail:vetdong@163.com
  • 基金资助:
    北京市科技计划项目(Z171100001517008)

Observation on the Therapeutic Effect of GS-441524 for Cats with Feline Infectious Peritonitis

MOU Danxia1, DONG Jun1,2, WU Fan1, LI Anqi2, TANG Yashu1, WANG Min1, LYU Yanli1,2   

  1. 1. College of Veterinary Medicine, China Agricultural University, Beijing 100193, China;
    2. China Agricultural University Veterinary Teaching Hospital, Beijing 100193, China
  • Received:2020-09-14 Online:2021-05-20 Published:2021-05-20

摘要: 试验旨在观察GS-441524对自然感染的猫传染性腹膜炎(FIP)病例的临床疗效,为临床用药提供参考。试验招募了25只于中国农业大学动物医院确诊为FIP的患猫,随机分为高剂量组(5 mg/(kg·d))(12只)和低剂量组(2.5 mg/(kg·d))(13只),每日皮下注射GS-441524治疗并记录体重、体温、注射药物的疼痛反应及每周的实验室及影像学检查结果以评价药物疗效。设定治疗周期为4周,部分病例根据实际情况延长治疗时间。结果显示,共计20只湿性FIP和3只干性FIP患猫完成试验,2只患猫退出。治疗时间为4~18周。20只湿性FIP患猫中,2只在1周内死亡,1只体腔积液增加,17只用药1周后积液减少,用药2~3周后积液消失。3只干性FIP患猫中,2只患猫的肠系膜淋巴结在用药1~2周后减小,1只无明显变化。所有患猫的精神和食欲在用药3~5 d内改善;体重在1~2周内开始增长;5只发烧的患猫用药2~3 d后体温恢复正常;14只贫血的患猫用药1~10周后恢复正常;16只患猫出现白细胞数量升高且淋巴细胞数量下降或中性粒细胞数量升高,用药1~2周内开始好转。所有患猫血清中白蛋白和球蛋白的比值(白球比)均<0.8,其中9只总蛋白升高,4只白蛋白降低,14只球蛋白升高,用药1~2周后开始好转。高剂量组的患猫4周药物有效率和治愈率分别为81.8%和60.0%,低剂量组的患猫4周药物有效率和治愈率分别为75.0%和22.2%。用药4周前后,高剂量组的患猫除白细胞总数(WBC)和白蛋白(ALB)外,其余指标均差异显著或极显著(P<0.05;P<0.01);而低剂量组的患猫仅体重差异显著。除血红蛋白(HGB)、WBC和ALB外,药物对患猫的体重、红细胞(RBC)、红细胞压积(HCT)、淋巴细胞(LYM)、中性粒细胞(NEU)、总蛋白(TP)、球蛋白(GLOB)及白球比(A/G)改善情况差异显著(P<0.05),且高剂量药物效果更佳。综上,GS-441524能有效治疗自然感染的FIP,高剂量(5 mg/(kg·d))疗效更佳,最短治疗周期为4周。

关键词: GS-441524; 猫传染性腹膜炎(FIP); 临床疗效

Abstract: In order to observe the effect of different doses of GS-441524 on naturally occurring feline infectious peritonitis(FIP),25 cats diagnosed with FIP in China Agricultural University Veterinary Teaching Hospital were randomly divided into high-dose group (5 mg/(kg·d))(12) and low-dose group (2.5 mg/(kg·d))(13).They were given GS-441524 everyday by subcutaneous injection and recorded daily weight,temperature,pain response of injection and weekly laboratory and imaging examination results.The treatment period was 4 weeks,and some cases were extended according to the actual condition.Finally,20 wet FIP cats and 3 dry FIP cats completed the test,2 cats quit the test.The whole medication was between 4 and 18 weeks.Of the 20 wet FIP cats,2 cats died within 1 week,1 cat's body cavity fluid increased,17 cats' body fluid decreased after 1 week of medication and then disappeared after 2 to 3 weeks of medication.Of the 3 dry FIP cats,2 cats had intestinal membrane lymph nodes that decreased after 1 to 2 weeks of medication,and 1 cat didn't change.The spirit and appetite of all cats improved within 3 to 5 days,weight began to increase within 1 to 2 weeks,5 cats with fever returned to normal after 2 to 3 days,14 anemia cats returned to normal after 1 to 10 weeks,16 cats showed an increase in the number of white blood cells and a decrease in the number of lymphocytes or an increase in the number of neutral granulocytes,and began to improve within 1 to 2 weeks.The ratio of albumin to globulin in all cat serums was less than 0.8,of which 9 cats had an increase in total protein,4 cats had a decrease in albumin,14 cats had an increase in globulin,and began to improve after 1 to 2 weeks.The effective and cure rate of 4 weeks' treatment in high-dose group were 81.8% and 60.0%,respectively.The effective and cure rate of 4 weeks' treatment in the low-dose group were 75.0% and 22.2%,respectively.In addition,statistical results showed significant or extremely significant differences in the indicators of cats in the high-dose group except for white blood cell count and albumin after 4 weeks of medication (P<0.05;P<0.01),while the cat in the low-dose group only had significant weight differences.In addition to hemoglobin,white blood cell count and albumin,the drug had significant differences in weight,red blood cells,red blood cell pressure,lymphocytes,neutral granulocytes,total protein and the ratio of albumin to globulin (P<0.05).Overall,GS-441524 was effective for naturally occurring FIP,and the optimum dosage was 5 mg/(kg·d).

Key words: GS-441524; feline infectious peritonitis (FIP); clinical effects

中图分类号: